Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hebart HF"'
Autor:
Pellé O; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Moreno S; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Lorenz MR; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Riller Q; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Fuehrer M; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Wuerttemberg-Hessen, Ulm, Germany; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Stolzenberg MC; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Maccari ME; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Lenoir C; University of Paris Cité, Paris, France; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Cheminant M; Clinical Hematology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; French National Reference Centre for Primary Immunodeficiencies (CEREDIH), Paris, France., Hinze T; Department of Pediatric Rheumatology and Immunology, University Hospital Münster, Münster, Germany., Hebart HF; Department of Internal Medicine, Kliniken Ostalb, Stauferklinikum, Mutlangen, Germany., König C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany., Schvartz A; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Schmitt Y; University of Paris Cité, Paris, France; Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 and INSERM US24/CNRS UAR3633, Paris, France., Vinit A; Sorbonne Université, UMS037, PASS, Plateforme de Cytométrie de la Pitié-Salpêtrière CyPS, Paris, France., Henry E; Genomics Platform, Translational Research Department, Research Center, Institut Curie, Paris Sciences et Lettres (PSL) Research University, Paris, France., Touzart A; Laboratory of Onco-Hematology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France., Villarese P; Laboratory of Onco-Hematology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France., Isnard P; Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France; Department of Pathology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Neveux N; Laboratory of Biological Nutrition, Faculty of Pharmacy, Paris University, Paris, France; Clinical Chemistry Department, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Landman-Parker J; Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP) Armand Trousseau, Paris, France., Picard C; University of Paris Cité, Paris, France; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, INSERM UMR 1163, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Fouyssac F; Pediatric Oncology and Hematology Unit, Children Hospital, Vandoeuvre-les-Nancy, Paris, France., Neven B; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Pediatric Immuno-hematology and Rheumatology Department, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Grimbacher B; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Speckmann C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Fischer A; University of Paris Cité, Paris, France; Pediatric Immuno-hematology and Rheumatology Department, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France; Collège de France, Paris, France., Latour S; University of Paris Cité, Paris, France; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France., Schwarz K; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Wuerttemberg-Hessen, Ulm, Germany., Ehl S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rieux-Laucat F; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France. Electronic address: frederic.rieux-laucat@inserm.fr., Rensing-Ehl A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Magérus A; University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Imagine Institute, INSERM UMR 1163, Paris, France. Electronic address: aude.magerus@inserm.fr.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Jan; Vol. 153 (1), pp. 203-215. Date of Electronic Publication: 2023 Oct 02.
Autor:
Ettrich TJ; Department of Internal Medicine I, Ulm University, Ulm, Delaware, USA., Perkhofer L; Department of Internal Medicine I, Ulm University, Ulm, Delaware, USA., Decker T; Private Practice, Onkologie Ravensburg, Ravensburg, Germany., Hofheinz RD; Interdisciplinary Tumor Center, University Hospital Mannheim, Mannheim, Germany., Heinemann V; Department of Medical Oncology and Comprehensive Cancer Center, Ludwig Maximilians University, Munich, Germany., Hoffmann T; Internal Medicine II, Klinikum Weimar, Weimar, Germany., Hebart HF; Medizinische Klinik, Klinikum Schwäbisch Gmünd, Stauferklinik, Mutlangen, Baden-Württemberg, Germany., Herrmann T; Medizinische Klinik, Westküstenklinikum Heide, Heide, Schleswig-Holstein, Germany., Hannig CV; Private Practice, Schwerpunktpraxis Hämatologie/Onkologie, Bottrop, Germany., Büchner-Steudel P; Internal Medicine I, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Güthle M; Department of Internal Medicine I, Ulm University, Ulm, Delaware, USA., Hermann PC; Department of Internal Medicine I, Ulm University, Ulm, Delaware, USA., Berger AW; Department of Internal Medicine I, Ulm University, Ulm, Delaware, USA., Seufferlein T; Department of Internal Medicine I, Ulm University, Ulm, Delaware, USA.
Publikováno v:
International journal of cancer [Int J Cancer] 2021 Mar 15; Vol. 148 (6), pp. 1428-1437. Date of Electronic Publication: 2020 Oct 04.
Autor:
Ettrich TJ, Perkhofer L, von Wichert G; Department of Internal Medicine, Schön-Klinik Hamburg-Eilbeck, Hamburg, Germany. goetz.wichert@gmx.de., Gress TM; Department of Gastroenterology, Endocrinology, Metabolism and Infectiology, Philipps University of Marburg, Marburg, Germany. gress@med.uni-marburg.de., Michl P; Department of Internal Medicine I, Martin-Luther-University, Halle (Saale), Germany. patrick.michl@uk-halle.de., Hebart HF; Department of Internal Medicine, Stauferklinikum Schwaebisch-Gmuend, Mutlangen, Germany. holger.hebart@stauferklinikum.de., Büchner-Steudel P; Department of Internal Medicine I, Martin-Luther-University, Halle (Saale), Germany. petra.buechner-steudel@uk-halle.de., Geissler M; Department of Internal Medicine, Oncology/Hematology, Gastroenterology, Esslingen Hospital, Esslingen, Germany. m.geissler@klinikum-esslingen.de., Muche R; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. rainer.muche@uni-ulm.de., Danner B; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. bettina.danner@uni-ulm.de., Kächele V; Praxis für Hämatologie und Onkologie Ulm, Ulm, Germany. volker.kaechele@gmx.de., Berger AW; Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081, Ulm, Germany. andreas.berger@uniklinik-ulm.de., Güthle M; Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081, Ulm, Germany. melanie.guethle@uniklinik-ulm.de., Seufferlein T; Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, D-89081, Ulm, Germany. thomas.seufferlein@uniklinik-ulm.de.
Publikováno v:
BMC cancer [BMC Cancer] 2016 Jan 15; Vol. 16, pp. 21. Date of Electronic Publication: 2016 Jan 15.
Autor:
Saussele S; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Krauss MP; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Hehlmann R; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Lauseker M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, München, Germany;, Proetel U; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Kalmanti L; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Hanfstein B; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Fabarius A; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Kraemer D; Klinik für Onkologie und Hämatologie, Klinikum, Oldenburg, Germany;, Berdel WE; Medizinische Klinik A, Universitätsklinikum, Münster, Germany;, Bentz M; Medizinische Klinik III, Städtisches Klinikum, Karlsruhe, Germany;, Staib P; Klinik für Hämatologie und Onkologie, St.-Antonius-Hospital, Eschweiler, Germany;, de Wit M; Klinik für Hämatologie, Onkologie und Palliativmedizin, Vivantes Klinikum Neukölln, Berlin, Germany;, Wernli M; Onkologie/Hämatologie und Transfusionsmedizin, Kantonsspital, Aarau, Switzerland;, Zettl F; Klinik für Hämatologie und Medizinische Onkologie, Universitätsmedizin, Göttingen, Germany;, Hebart HF; Zentrum für Innere Medizin, Stauferklinikum, Mutlangen, Germany;, Hahn M; Ambulantes Onkologie Zentrum, Anspach, Germany;, Heymanns J; Praxisklinik für Hämatologie und Onkologie, Koblenz, Germany;, Schmidt-Wolf I; Med. Klinik III, Onkologie, Hämatologie und Rheumatologie, Universitätsklinikum, Bonn, Germany;, Schmitz N; Abteilung für Hämatologie und Stammzelltransplantation, Asklepios Klinik Hamburg St. Georg, Hamburg, Germany;, Eckart MJ; Internistische Schwerpunktpraxis, Erlangen, Germany;, Gassmann W; Klinik für Hämatologie und Internistische Onkologie, St. Marien-Krankenhaus, Siegen, Germany;, Bartholomäus A; Medizinische Klinik II, St. Bernward Krankenhaus, Hildesheim, Germany;, Pezzutto A; Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Campus Benjamin Franklin, Charité-Universitätsmedizin, Berlin, Germany;, Leibundgut EO; Universitätsspital Inselspital, Bern, Switzerland;, Heim D; Klinik für Hämatologie, Universitätsspital, Basel, Switzerland;, Krause SW; Medizinische Klinik 5, Universitätsklinikum, Erlangen, Germany;, Burchert A; Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum, Marburg, Germany; and., Hofmann WK; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;, Hasford J; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, München, Germany;, Hochhaus A; Abteilung Hämatologie/Internistische Onkologie, Universitätsklinikum, Jena, Germany., Pfirrmann M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, München, Germany;, Müller MC; III Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany;
Publikováno v:
Blood [Blood] 2015 Jul 02; Vol. 126 (1), pp. 42-9. Date of Electronic Publication: 2015 Apr 27.